Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnolia: Ganaxolone IV in Postpartum Depression
NCT03228394Phase 2Completed
- Sponsor
- Marinus Pharmaceuticals
- Start
- Jun 2017
- Primary completion
- May 2019
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of ganaxolone in postpartum depression (PPD), sponsored by Marinus Pharmaceuticals. Started Jun 2017; status: completed.
02
Drugs
ganaxolone
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on NCT03228394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03228394.